Haemonetics Corp Mass

CUSIP 405024100COMHAEQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

13.1%

Max % of class reported

Institutional Holders

315

13F filers (latest quarter)

42 filings · latest Mar 3, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Mar 3, 2026	North Peak Capital Management, LLC	13G	11.0%	2.37M	SEC
2	Feb 13, 2026	Aqr Capital Management, LLC	13G	6.8%	3.16M	SEC
3	Aug 12, 2025	Wellington Management Group LLP	13G/A	4.6%	2.20M	SEC
4	May 14, 2025	T. Rowe Price Investment Management, Inc.	13G/A	4.4%	2.20M	SEC
5	May 12, 2025	Wellington Management Group LLP	13G/A	5.4%	2.69M	SEC
6	Apr 4, 2025	Capital Research Global Investors	13G/A	3.1%	1.58M	SEC
7	Nov 14, 2024	T. Rowe Price Investment Management, Inc.	13G	5.6%	2.85M	SEC
8	Nov 12, 2024	Capital Research Global Investors	13G/A	8.7%	4.44M	SEC
9	Nov 8, 2024	Wellington Management Group LLP	13G/A	8.3%	4.23M	SEC
10	Feb 13, 2024	Neuberger Berman Group LLC	13G/A	7.0%	3.53M	SEC

See the full Schedule 13D/13G history for Haemonetics Corp Mass.

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Blackrock, Inc.	5.62M	$316.74M
2	Neuberger Berman Group LLC	3.56M	$200.61M
3	Aqr Capital Management LLC	3.36M	$185.68M
4	State Street Corp	1.77M	$99.92M
5	Arrowstreet Capital, Limited Partnership	1.38M	$77.95M
6	River Road Asset Management, LLC	1.33M	$74.85M
7	Dimensional Fund Advisors LP	1.33M	$74.73M
8	Fmr LLC	1.28M	$71.91M
9	Geode Capital Management, LLC	1.22M	$68.71M
10	North Peak Capital Management, LLC	999.0K	$56.30M